Insider · CIK 0001873374
Peter Dore Rawlinson
Files at LCID (Lucid Group, Inc.). First filing -, latest -.
In brief
Peter Dore Rawlinson files SEC Form 4 as CEO and director at LCID (Lucid Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter Dore Rawlinson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | LCID Lucid Group, Inc. | FTax withholding Class A Common Stock | -476,261 | $2.10 | $1.0M | 18,054,380 | Dec 9, 2024 |
| Dec 6, 2024 | LCID Lucid Group, Inc. | MOption exercise Class A Common Stock | +181,467 | $0.83 | $151k | 18,235,847 | Dec 9, 2024 |
| Dec 6, 2024 | LCID Lucid Group, Inc. | MOption exercise Stock Options(Right to Buy)derivative | -181,467 | $0.00 | $0 | 7,569,809 | Dec 9, 2024 |
Questions about Peter Dore Rawlinson
Answered from the filings on this page, as of the latest one.
Is Peter Dore Rawlinson buying or selling?
Peter Dore Rawlinson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter Dore Rawlinson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Dore Rawlinson has 0.
Where does Peter Dore Rawlinson file Form 4?
Peter Dore Rawlinson has filed Form 4 at LCID (Lucid Group, Inc.) as CEO & Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.